Revenue
-
Net Income
$227,838
▲ 1304.8% YoY
EPS
-
Cash
$81,179
▲ 9763.8% YoY
FY 2014 · As of 2014-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 31, 2026 | 3.5K | $0.05 | $172 | Form 4 ↗ |
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 24, 2026 | 2.1K | $0.06 | $116 | Form 4 ↗ |
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 20, 2026 | 11.5K | $0.04 | $518 | Form 4 ↗ |
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 19, 2026 | 10.0K | $0.06 | $590 | Form 4 ↗ |
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 14, 2026 | 1.8K | $0.06 | $112 | Form 4 ↗ |
CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Buy | Aug 7, 2026 | 7.7K | $0.07 | $501 | Form 4 ↗ |